We don't own it... We help you sell it.
|
|
We don't own it... We help you sell it.
|
Login | Register |
|
The Medical Industry Business Weekly |
| July 03, 2008 |
|
Other HeadlinesHouse passed plan but Senate failed to stamp its approval. AMA is outraged; ACP dismayed and frustrated. Claims processing now frozen for 10 days.
Plaintiffs' argument fails to delay implementation of controversial program.
MRI and CT ISO teams with California firm.
Mike Kline and DOTmed Certified Mike Koda of Minnesota Medical Redistributors Haven't Given Up Their Day Jobs
Second sourcing and repair experts are moonlighting for now.
Company awarded a three-year term of accreditation in digital mammography mobile services as the result of a recent survey by the American College of Radiology.
Have News for Us?Submit your news on the industry, people, or companies.More Industry HeadlinesCongress Goes on Break Without Blocking Medicare Cuts House passed plan but Senate failed to stamp its approval. AMA is outraged; ACP dismayed and frustrated. Claims processing now frozen for 10 days. DC Federal Court Refuses Injunction on Medical DME Bidding Program Plaintiffs' argument fails to delay implementation of controversial program. Visit DOTmed at AHRMM Conference The 46th Annual AHRMM Conference & Exhibition is saddling up in San Antonio, TX this year, from July 20-23. Be sure to visit DOTmed at Booth #736. Siemens to Cut Workforce? Reports are unconfirmed, but could be significant, projecting a major downsizing of more than 17,000 people worldwide. Poor Patient Discharge Instructions Often Lead to Harm More than 800 reports submitted from Pennsylvania hospitals identify a variety of problems occurring at discharge; 30 percent of those patients did not receive verbal or written discharge instructions. PHILIPS Intera 1.5T Mobile MRI -- last chance to get your bid in! Also see the other great lasers, imaging systems, and more... all on your favorite website for used medical equipment! Bill on DME Bidding Delay Runs Into Challenges From Senate Vote, Bipartisan Opposition House bill fails first Senate try; Senators submit letter urging opposition to delay of DMEPOS bidding program. Warning by FDA About Bone Growth Products Made by Medtronic, Inc. and Stryker Corp. The U.S. Food and Drug Administration warned that bone growth products made by Medtronic, Inc. and Stryker Corp. have been linked to life-threatening complications when used without approval in neck fusion surgeries. Caution Urged During Fireworks Season Health panel urges caution with fireworks this holiday. Automated MRI Technique Assists in Earlier Alzheimer's Diagnosis MRI with automated segmentation quickly and accurately measures tissue loss in the hippocampus, where nerve cell death is pronounced in Alzheimer's. 
Food and Drug
Administration Legislative Work Continues on Revamping FDAby Astrid Fiano, Writer
Senate legislators are targeting improvements for the Food and Drug Administration. A bipartisan group has recommended that the FDA receive more funding after listening to testimony during a Senate Appropriations subcommittee hearing this month. Sen. Herb Kohl (D-WI) said the agency was "seriously underfunded," according to a recent New York Times article. In testimony to the subcommittee, FDA Commissioner Andrew C. von Eschenbach, M.D., discussed the agency's budget request and the stressed the need to modernize the FDA's workforce and infrastructure.
In the House, Energy and Commerce Committee Chair John Dingell (D-Mich.) has new legislation proposed for increased FDA funds and regulatory changes. During a Senate subcommittee on health for the Committee on Oversight and Commerce hearing last week, Rep. Dingell told the committee members that the FDA is "starved" for resources. Rep. Dingell's proposals are in The Discussion Draft Food and Drug Administration Globalization Act. The Act builds upon previous House bills and results from subcommittee investigations, and has changes to current FDA law including: an annual registration fee for domestic and foreign drug and device establishments; a requirement for domestic and foreign drug and device establishments to be inspected every 2 years; giving the Secretary of Health and Human Services the same recall authority with respect to drugs as the Secretary has with respect to devices; and a requirement for importers of food, drugs, devices, and cosmetics to register with the Secretary and to pay an annual registration fee of $10,000. The FDA itself has previously stressed to Congress this year that it needs considerably more funding. Janet Woodcock, deputy commissioner for scientific affairs and chief medical officer, testified in February to the House Appropriations Subcommittee on Agriculture, Rural Development, FDA and Related Agencies concerning budgetary needs for import investigations and better prescription drug-tracking. Shortly thereafter, in light of concerns over the Heparin problems, Congresswoman Rosa L. DeLauro (D-CT) called for a larger FDA budget of $145 million over 2007 funding, but also for less influence on the agency from drug companies and better management. More information: http://appropriations.senate.gov/hearings.cfm?s=arg http://www.house.gov/delauro/ http://www.dotmed.com/news/story/5424/ Please Send us your Comments. |
Forward to a Friend